Pathophysiology of febrile nonhemolytic transfusion reactions.
about
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusionLeukoreduction for the prevention of adverse reactions from allogeneic blood transfusionPharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactionsLeucoreduction of blood components: an effective way to increase blood safety?Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses.A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis.Evidence-based recommendations for the use of WBC-reduced cellular blood components.Signs and symptoms associated with the transfusion of WBC-reduced RBCs and non-WBC-reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study.Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.Transfusion premedications: a growing practice not based on evidence.Clinical relevance of the HLA system in blood transfusion.Red cell transfusion and the immune system.Retrospective evaluation of the effect of red blood cell product age on occurrence of acute transfusion-related complications in dogs: 210 cases (2010-2012).Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX.Effect of premedication and other factors on the occurrence of acute transfusion reactions in dogs.Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012.[Fever during blood transfusion. A case of coincidence instead of causality].A revised classification scheme for acute transfusion reactions.Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.Biological response modifiers in photochemically pathogen-reduced versus untreated apheresis platelet concentrates.Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial.Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patients.Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage.Cytokine concentration in stored canine erythrocyte concentrates.Chemokine receptors expressed on T cells in packed red blood cell units change over storage time.Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers.Clinical response and transfusion reactions of sheep subjected to single homologous blood transfusion.
P2860
Q24187243-68411CD0-C7FF-412A-A02C-41D6080875D4Q24201602-1A563042-2B45-4D0F-928B-E8C22A7DFE06Q24234953-FD700743-5CCF-4171-BEE5-F17C1AB4AC31Q26771857-FA6DEB96-15A3-4A7B-9350-7D7779638719Q30235391-17511B0E-03EC-4924-B734-BC4826EBB28CQ33618448-A07A3606-075B-48FD-91D8-70CB84E44262Q33953454-F48FC83A-95F6-4BE4-8341-9DAFD8F9A714Q34405086-8AA342DC-7369-4916-A287-F1FC46AFF023Q34564946-267F1A27-962F-4FFE-8F99-ABF0FF89C61AQ35792449-2613F628-5EC2-4ABC-A2B2-9E0BB51516EFQ36237664-DA879402-231F-47A2-B4A5-D6A008068D34Q36831189-D0F2190F-CAD5-468A-95D2-ABEDAB34599BQ37871065-0AB7B95E-5D4D-4AA7-9859-FFF3CD8404C9Q38273784-A0A68114-4C47-46A5-B1FC-CB4E00C56427Q39350639-A6433FDB-253F-45DD-8119-9544A731677BQ40059443-FC931285-BA53-423D-A619-2A9940B430C5Q40150149-5753AEC4-BD62-4F06-8CC4-00D79630CDD0Q40179540-5E8376B7-E225-4831-AC2A-8435D4FC9C44Q40235756-E8658F67-8CC1-4CBB-8FB5-EDA35593A9DEQ40454545-2A20BBFC-9153-46CB-B4D7-7B173FCA6010Q40577692-185FFB5D-C75C-4EC8-B53C-5562E8722E94Q40579927-DEA058C5-9A85-4FE3-BB7B-DE13816680D3Q41655074-859A41EC-5A7E-48D7-84BD-6E4B856A4158Q41965815-6CBEC6F3-71EE-4B37-B10C-EF6B8615092CQ44059748-DABAE8AB-051D-4213-AD07-8FC2B50DC9F1Q50498673-58A2E5C3-AE87-4D8A-813F-AC5D71F5DA4CQ50675488-11F725FB-CDC0-4136-B29E-2A845AF1365FQ50702616-FC77E970-006A-45BD-AD31-FD43077979BBQ50726361-FABCE11D-8D06-480F-B9E8-77E5AB7099CDQ50797044-3544FFFA-6F93-42BF-BDE8-1E163B2D7603Q51672112-50F18307-D955-4218-A9F8-01C680715B29
P2860
Pathophysiology of febrile nonhemolytic transfusion reactions.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Pathophysiology of febrile nonhemolytic transfusion reactions.
@ast
Pathophysiology of febrile nonhemolytic transfusion reactions.
@en
type
label
Pathophysiology of febrile nonhemolytic transfusion reactions.
@ast
Pathophysiology of febrile nonhemolytic transfusion reactions.
@en
prefLabel
Pathophysiology of febrile nonhemolytic transfusion reactions.
@ast
Pathophysiology of febrile nonhemolytic transfusion reactions.
@en
P1476
Pathophysiology of febrile nonhemolytic transfusion reactions.
@en
P2093
P304
P356
10.1097/00062752-199911000-00012
P577
1999-11-01T00:00:00Z